KindlyMD, Inc. (NASDAQ:NAKA) Receives $0.75 Average Price Target from Brokerages

KindlyMD, Inc. (NASDAQ:NAKA) has earned a consensus recommendation of “Hold” from the five research firms that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating on the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $0.75.

Several analysts have commented on the stock. B. Riley Financial decreased their price target on shares of KindlyMD from $1.00 to $0.50 and set a “buy” rating on the stock in a research note on Monday, February 23rd. Maxim Group decreased their price target on shares of KindlyMD from $1.50 to $0.75 and set a “buy” rating on the stock in a research note on Monday, April 6th. TD Cowen assumed coverage on shares of KindlyMD in a research note on Friday, April 10th. They issued a “buy” rating and a $1.00 price target on the stock. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of KindlyMD in a research note on Friday, March 27th.

KindlyMD Stock Up 3.7%

Shares of NAKA stock opened at $0.25 on Friday. The stock has a market cap of $170.09 million, a P/E ratio of -0.28 and a beta of 26.73. KindlyMD has a 52 week low of $0.21 and a 52 week high of $34.77. The company’s fifty day simple moving average is $0.25 and its two-hundred day simple moving average is $0.47.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Osaic Holdings Inc. purchased a new position in KindlyMD in the second quarter worth about $215,000. Vontobel Holding Ltd. purchased a new position in KindlyMD in the third quarter worth about $335,000. Dynamic Technology Lab Private Ltd purchased a new position in KindlyMD in the third quarter worth about $369,000. Geode Capital Management LLC grew its position in KindlyMD by 76.2% in the second quarter. Geode Capital Management LLC now owns 19,394 shares of the company’s stock worth $484,000 after acquiring an additional 8,386 shares in the last quarter. Finally, Tower Research Capital LLC TRC grew its position in KindlyMD by 1,638.4% in the third quarter. Tower Research Capital LLC TRC now owns 33,152 shares of the company’s stock worth $827,000 after acquiring an additional 31,245 shares in the last quarter.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.